Tag: Beam Therapeutics Inc.

The stock of Beam Therapeutics Inc (BEAM) has seen a -12.35% decrease in the past week, with a -27.42% drop in the past month, and

The 36-month beta value for BEAM is at 1.78. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0

Moreover, the 36-month beta value for BEAM is 1.77. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0

The stock of Beam Therapeutics Inc (BEAM) has gone down by -6.69% for the week, with a 9.65% rise in the past month and a